Study Shows Health Benefits of Walnuts
the ONA take:
According to a new study published in the Journal of Medicinal Food, researchers at University of California, Davis, in Davis, California, have found that consuming a diet rich in whole walnuts or walnut oil decreased the rate of prostate cancer growth, reduced cholesterol, and increased insulin sensitivity in mice.
In addition, the walnut-rich diet reduced insulin-like growth factor 1 (IGF-1), which has been shown to cause prostate and breast cancer. For the study, researchers sought to investigate which part of walnuts cause the health benefits that have been identified in previous studies. Researchers fed mice either whole walnuts, walnut oil, or a mixture of walnut-like fat for 18 weeks.
They found that the walnuts and walnut oil, but not the fatty acid mixture, caused health benefits like decreased prostate cancer growth and decreased cholesterol. The findings suggest that the meat and oil of walnuts cause health benefits, but not the omega-3 fatty acids of the walnut; however, it could also be a combination of the three components. The study also found that the health benefits of walnuts are not magnesium, selenium, or zinc.
The researchers note that although this study does not prove that the benefits of walnuts will translate from mice to humans, it may be beneficial to incorporate walnuts into a diet.
Diet rich in whole walnuts or walnut oil decreased the rate of prostate cancer growth.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|